SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-282726
Filing Date
2023-11-24
Accepted
2023-11-24 14:06:01
Documents
14
Period of Report
2023-11-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d261817d8k.htm   iXBRL 8-K 26684
2 EX-5.1 d261817dex51.htm EX-5.1 9799
6 GRAPHIC g261817g1123025438289.jpg GRAPHIC 2535
  Complete submission text file 0001193125-23-282726.txt   169892

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA harp-20231124.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20231124_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20231124_pre.xml EX-101.PRE 11712
8 EXTRACTED XBRL INSTANCE DOCUMENT d261817d8k_htm.xml XML 3486
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 231436470
SIC: 2836 Biological Products, (No Diagnostic Substances)